Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
      .feedback feedback to editors .

      chemotherapy involved two hours at the hospital every other week. he'd leave wearing a fanny pack that would continue to deliver treatment for 48 straight hours, one slow drip at a time. .

      latest .
      .